India In-Vitro Diagnostics Market to be Dominated by Reagents and Kits through 2029
The increasing awareness about assisted
reproductive technologies is expected to drive the growth of the India in-vitro
diagnosticsmarket during the forecast period.
According to TechSci Research report, “IndiaIn-Vitro
Diagnostics Market - By Region, Competition, Forecast, and Opportunities, 2029”,
the India in-vitro diagnostics market is anticipated to grow at an impressive
rate during the forecast period. This can be ascribed due to the
increase in point of care testing (POC). POC testing offers several advantages
over traditional laboratory-based testing, including faster turnaround times,
improved patient outcomes, and reduced healthcare costs. POC testing is
especially valuable in resource-limited settings, such as rural areas, where
access to laboratory-based testing may be limited. In India, the growing demand
for POC testing is being driven by several factors. Firstly, the country has a
large population, and there is a need for rapid and accurate diagnostic tests
to manage infectious diseases such as tuberculosis and malaria. Secondly, India
has a significant burden of non-communicable diseases such as diabetes and
cardiovascular diseases, which require regular monitoring and management. POC
testing offers a convenient and cost-effective way to monitor these conditions.
The Indian government has also recognized the potential of POC testing to
improve healthcare outcomes and reduce costs. For instance, the National Health
Mission (NHM) has launched several initiatives to promote POC testing in rural
areas, including the establishment of POC testing centers and the deployment of
mobile POC testing units.
Major trend which is there in the India in-vitro
diagnostics market is digital health and connectivity. Digital health refers to
the use of technology to improve healthcare delivery, while connectivity refers
to the ability to share information electronically between different healthcare
providers and patients. One of the key areas where digital health and
connectivity are being utilized in the in-vitro diagnostics market in India is
in the development of telemedicine platforms, which enable patients to consult
with healthcare providers remotely. Telemedicine platforms are particularly
valuable in rural areas, where access to healthcare is often limited. By enabling
patients to consult with healthcare providers remotely, telemedicine platforms
can help to improve access to healthcare, reduce healthcare costs, and improve
patient outcomes.
Challenge which is being faced by the India
in-vitro diagnostics market is limited access to advanced testing facilities.
Advanced testing technologies and platforms require specialized equipment,
trained personnel, and infrastructure, which may not be readily available in
all regions of the country, especially in rural and remote areas. This lack of
access to advanced testing facilities can limit the availability of diagnostic
testing services for some patients and can result in delays in diagnosis and
treatment. It can also contribute to disparities in healthcare access and outcomes.
Addressing this challenge will require investment in healthcare infrastructure
and resources to expand access to advanced testing facilities across the
country. This can involve increasing the number of laboratories and testing
centers, improving transportation and logistics, and providing training and
support for healthcare professionals. It may also require collaboration between
government agencies, healthcare providers, and industry stakeholders to develop
and implement strategies for expanding access to advanced testing facilities in
India.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "India In-Vitro Diagnostics Market”
The India in-vitro diagnostics market can be
segmented by product type, technology, application, end user, and region. Based
on technology, the market can be segmented into immunoassay, hematology,
clinical chemistry, molecular diagnostics, microbiology, and others. Molecular
diagnostics is a technique that involves the analysis of biological markers or
genetic material to diagnose or monitor diseases, detect genetic variations,
and assess the risk of developing certain diseases. Molecular diagnostics tests
can be performed on various biological specimens such as blood, urine, tissue,
and saliva. The process involves the extraction and analysis of DNA, RNA, and
other nucleic acids from the biological specimen. The genetic material is then
amplified using polymerase chain reaction (PCR) or other techniques to increase
the amount of DNA or RNA for detection. The amplified material is then analyzed
using various methods such as sequencing, hybridization, and other molecular
techniques. Molecular diagnostics has revolutionized the field of diagnostic
testing by enabling the rapid and accurate detection of a wide range of
diseases, including infectious diseases, genetic disorders, and cancer.
Based on end user, the India in-vitro diagnostics
market can be segmented into hospitals & clinics, diagnostic centers &
laboratories, and others. These centers and laboratories are responsible for
performing diagnostic tests and providing accurate results to healthcare
providers and patients. As the demand for diagnostic testing continues to grow,
the need for reliable and efficient diagnostic centers and laboratories also
increases. This creates opportunities for companies in the India in-vitro
diagnostics market to provide innovative and high-quality diagnostic testing products
and services.
Major companies operating in the India in-vitro
diagnostics market are:
- J Mitra & Co Pvt Ltd.
- Advatech Healthcare Pvt Ltd.
- Tulip Diagnostics PVT. Ltd.
- Transasia Bio-Medicals Ltd.
- BD India Pvt Ltd.
- Siemens Healthcare Pvt. Ltd.,
- Bio-Rad Laboratories India Pvt. Ltd
In 2021, Meril Diagnostics announced the launch of
its MiraCle Dx SARS-CoV-2 RT-PCR Test, which is designed to detect the COVID-19
virus. This test is expected to help in increasing the testing capacity in
India and improving the accuracy of COVID-19 testing.
In 2020, Transasia Bio-Medicals announced a
partnership with IVD company Erba Mannheim to manufacture and distribute Erba
Mannheim's IVD products in India. This partnership is expected to help in
expanding the product portfolio of both companies in India.
In 2020, Becton, Dickinson and Company (BD) India
announced the launch of its BD Cor System, which is used for automated
molecular testing in clinical laboratories. This system is expected to help in
increasing the efficiency and accuracy of COVID-19 testing in India.
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“The India in-vitro diagnostics market is expected
to grow during the forecast period due to the rising demand for preventive
medicine with medical benefits along with growing preference for clinical
chemistry across the region. The increasing demand for clinical chemistry
testing is driven by the need for accurate, reliable, and timely diagnostic
information to improve patient outcomes and reduce healthcare costs. Besides,
increasing concern about healthy lifestyles and growing expenditure on health
and wellness are further expected to create lucrative opportunities for the
market growth,” said Mr. Karan Chechi, Research Director with TechSci Research,
a research-based global management consulting firm.
“India In-Vitro Diagnostics Market, By Product Type
(Instruments, Reagents, and Software & Services), By Technology
(Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics,
Microbiology, and Others), By Application (Infectious Diseases, Diabetes,
Oncology, Cardiology, Nephrology, and Others), By End User (Hospitals &
Clinics, Diagnostic Centers & Laboratories, and Others), and By Region, Competition,
Forecast, and Opportunities, 2029”, has evaluated the future growth potential of
the India in-vitro diagnostics market and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in
the India in-vitro diagnostics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com